Julie R. Gralow, MD: The Atlas Trial. Tamoxifen For Five Years or Ten Years?
Description: Dr. Julie Gralow sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) for a four-part interview. This is the second in the four-part interview where she discusses the Atlas Trial and the new data concerning Tamoxifen.
Julie Gralow, MD is a medical oncologist who specializes in treating women with breast cancer. She is the Director, Breast Medical Oncology, Seattle Cancer Care Alliance -- Clinical Research Division, Associate Member, Fred Hutchinson Cancer Research Center -- Professor, Medical Oncology Division, University of Washington School of Medicine
Shared By : vitaloptions
Posted on : 02/26/13
Added : 6 years ago